Skip to main content
NewslettersWatchlist

Gsk Plc ADR(GSK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low40.79
Day High41.26
Open:41.25
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
You Can Stop Looking, Here's the Perfect Stock for the Current Market
Investor Brand Network
Annovis Bio (NYSE: ANVS) Releases Promising Clinical Data As Alzheimer’s Therapeutics Market Grows
GlobeNewswire
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033   
Motley Fool
Is GSK a Top-Value Stock Right Now?
Motley Fool
3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
BayStreet.ca
Cancer Rates Surge: Key Biotech Stocks Leading the Charge in Oncology Drug Development
GlobeNewswire
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
Motley Fool
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Barchart
Option Volatility And Earnings Report For May 13- 17
The Globe and Mail
Why this money manager believes ESG investing is out and impact investing is in
Motley Fool
Down 75%. Is Agenus Stock a Buy on the Dip?
Motley Fool
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Motley Fool
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
Newswire.ca
Find Therapeutics Announces Appointment of Dr. Anthony Johnson to its Board of Directors
Barchart
Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe
Barchart
1 Pharma Stock to Buy Near 52-Week Highs
The Globe and Mail
Market movers: Stocks seeing action on Wednesday - and why
Barchart
2 Best Growth Stocks to Buy with $1,000 Right Now
Barchart
1 Pharma Stock to Buy on Strong Vaccine Growth Potential
Motley Fool
3 Great Foreign Companies to Invest in Right Now
MarketBeat
GSK is a remedy for the winter investment blahs
Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen

Profile

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.